RALEIGH, N.C., Feb. 25, 2016 (GLOBE NEWSWIRE) -- INC Research Holdings, Inc. (Nasdaq:INCR), a leading global Phase I to Phase IV contract research organization, today reported financial results for the fourth quarter and year ended December 31, 2015.
“INC’s continued focus on therapeutic expertise, strong site relationships and operational excellence through our proven Trusted Process® yielded strong results for our customers and shareholders in 2015,” said Chief Executive Officer Jamie Macdonald. “During our first full year as a public company, we achieved four quarters of strong revenue growth and record new business awards, and received recognition as ‘Best CRO’ by a distinguished panel of life science industry executives at the 11th Annual Scrip Awards. These results demonstrate our significant progress in building an innovative, forward-thinking clinical development partner to deliver improved value for our customers in the digital healthcare environment. We look forward to building on this momentum in 2016 and positioning INC Research as the ‘CRO of Choice’ for all stakeholders including employees, customers, sites and investors.”
